|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2007-11-16
|
|
pubmed:abstractText |
Pancreatic cancer is an exceptionally lethal disease with an annual mortality nearly equivalent to its annual incidence. This dismal rate of survival is due to several factors including late presentation with locally advanced, unresectable tumors, early metastatic disease, and rapidly arising chemoresistance. To study the mechanisms of chemoresistance in pancreatic cancer we developed two gemcitabine-resistant pancreatic cancer cell lines.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD44,
http://linkedlifedata.com/resource/pubmed/chemical/Antimetabolites, Antineoplastic,
http://linkedlifedata.com/resource/pubmed/chemical/Cadherins,
http://linkedlifedata.com/resource/pubmed/chemical/Deoxycytidine,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-met,
http://linkedlifedata.com/resource/pubmed/chemical/beta Catenin,
http://linkedlifedata.com/resource/pubmed/chemical/flotillins,
http://linkedlifedata.com/resource/pubmed/chemical/gemcitabine
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1534-4681
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3629-37
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:17909916-Antigens, CD44,
pubmed-meshheading:17909916-Antimetabolites, Antineoplastic,
pubmed-meshheading:17909916-Cadherins,
pubmed-meshheading:17909916-Cell Adhesion,
pubmed-meshheading:17909916-Cell Movement,
pubmed-meshheading:17909916-Deoxycytidine,
pubmed-meshheading:17909916-Drug Resistance, Neoplasm,
pubmed-meshheading:17909916-Epithelium,
pubmed-meshheading:17909916-Flow Cytometry,
pubmed-meshheading:17909916-Humans,
pubmed-meshheading:17909916-Immunoblotting,
pubmed-meshheading:17909916-Membrane Proteins,
pubmed-meshheading:17909916-Mesoderm,
pubmed-meshheading:17909916-Neoplasm Invasiveness,
pubmed-meshheading:17909916-Pancreatic Neoplasms,
pubmed-meshheading:17909916-Proto-Oncogene Proteins c-met,
pubmed-meshheading:17909916-Tumor Cells, Cultured,
pubmed-meshheading:17909916-beta Catenin
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Development and characterization of gemcitabine-resistant pancreatic tumor cells.
|
|
pubmed:affiliation |
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
